cognitive cybersecurity intelligence
Singapore biotech firm MiRXES Pte Ltd, which focuses on early detection cancer tests, has opened the first industry 4.0 (i4.0) in vitro diagnostic (IVD) manufacturing facility in Southeast Asia.
The S$8M (US$5.8M) 15,000-square-feet facility is located at JTC MedTech Hub. The company…
Source: www.labiotech.eu – Read more
Subscribe to HEAL Security Dispatch for the latest healthcare cybersecurity news and analysis.
What You Should Know: – Optain Health, a healthcare technology company specializing in AI, robotic retinal imaging, and teleophthalmology secures $26M in Series A funding
Chinese APT Hits Philippine Military Firm with New EggStreme Fileless Malware Hackread
A remote code execution vulnerability has been discovered in the Cursor AI Code Editor, enabling a malicious code repository to run code on a user’s
Apple users beware – hackers crack iCloud Calendar invites to sneak malware onto your system, here’s how to stay safe TechRadar
